FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945408945> ?p ?o ?g. }

• W2945408945 endingPage "e028832" @default.
• W2945408945 startingPage "e028832" @default.
• W2945408945 abstract "Introduction Electronic cigarettes (EC) mainly with nicotine content are widely used worldwide. Although the number of publications about its use is increasing exponentially, evidence-based, unbiased, conclusive, head-to-head comparisons about its efficacy and safety as an aid for smoking cessation are lacking. Methods and analysis Design: randomised, placebo and reference treatment-controlled, multicentre, double-blind, double-dummy, parallel-group trial. Participants: smokers smoking at least 10 cigarettes/day in the past year and motivated to quit, aged 18–70 years. Interventions : (A) EC without nicotine (ECwoN) plus placebo tablets of varenicline administered by oral route: placebo condition , (B) EC with nicotine (ECwN) plus placebo tablets of varenicline: ECwN condition. Voltage regulated EC will be used with liquid containing 12 mg/mL of nicotine for ad libitum use. Flavour : blond tobacco. (C) Reference : ECwoN plus 0.5 mg varenicline tablets: varenicline condition. Varenicline administered according to the marketing authorisationauthorisation. Treatment duration : 1 week+3 months. Primary outcome: continuous smoking abstinence rate (CAR) (abstinence from conventional/combustible cigarettes) during the last 4 weeks (weeks 9–12) of the treatment period defined as self-report of no smoking during the previous 2 weeks and expired air carbon monoxide ≤8 at visit 4 at week 10 after target quit date (TQD), that is, 11 weeks after treatment initiation AND at visit 5, week 12 after TQD, that is, 13 weeks after treatment initiation. Secondary outcomes : safety profile; point prevalence abstinence rate; CAR confirmed by urinary anabasine concentration; changes in cigarettes/day consumption; craving for tobacco and withdrawal symptoms with respect of baseline. Ethics and dissemination The ethics committee approval was obtained on 17 April 2018. All data collected about the study participants will be anonymised. Investigators will communicate trial results to participants, health authorities, healthcare professionals, the public and other relevant groups without any publication restrictions. Trial registration number NCT03630614 ; Pre-results." @default.
• W2945408945 created "2019-05-29" @default.
• W2945408945 creator A5011164326 @default.
• W2945408945 creator A5015611967 @default.
• W2945408945 creator A5039501435 @default.
• W2945408945 creator A5048905515 @default.
• W2945408945 creator A5052636813 @default.
• W2945408945 creator A5059382937 @default.
• W2945408945 creator A5074251150 @default.
• W2945408945 date "2019-05-01" @default.
• W2945408945 modified "2023-10-18" @default.
• W2945408945 title "Randomised, placebo-controlled, double-blind, double-dummy, multicentre trial comparing electronic cigarettes with nicotine to varenicline and to electronic cigarettes without nicotine: the ECSMOKE trial protocol" @default.
• W2945408945 cites W1794449622 @default.
• W2945408945 cites W1859891561 @default.
• W2945408945 cites W1986333129 @default.
• W2945408945 cites W1989750897 @default.
• W2945408945 cites W1990025032 @default.
• W2945408945 cites W2011149006 @default.
• W2945408945 cites W2013319150 @default.
• W2945408945 cites W2015259201 @default.
• W2945408945 cites W2054488397 @default.
• W2945408945 cites W2054897163 @default.
• W2945408945 cites W2096533285 @default.
• W2945408945 cites W2100346673 @default.
• W2945408945 cites W2106457238 @default.
• W2945408945 cites W2112457560 @default.
• W2945408945 cites W2128364692 @default.
• W2945408945 cites W2135504811 @default.
• W2945408945 cites W2139839426 @default.
• W2945408945 cites W2145604066 @default.
• W2945408945 cites W2167489015 @default.
• W2945408945 cites W2167990168 @default.
• W2945408945 cites W2171202391 @default.
• W2945408945 cites W2233881276 @default.
• W2945408945 cites W2239337157 @default.
• W2945408945 cites W2258296723 @default.
• W2945408945 cites W2340896985 @default.
• W2945408945 cites W2404396929 @default.
• W2945408945 cites W2531489008 @default.
• W2945408945 cites W2586197770 @default.
• W2945408945 cites W2590905893 @default.
• W2945408945 cites W2747717603 @default.
• W2945408945 cites W2818717431 @default.
• W2945408945 cites W2884174719 @default.
• W2945408945 cites W2913337886 @default.
• W2945408945 cites W4241186196 @default.
• W2945408945 cites W4254121089 @default.
• W2945408945 cites W4292672078 @default.
• W2945408945 cites W4294253676 @default.
• W2945408945 doi "https://doi.org/10.1136/bmjopen-2018-028832" @default.
• W2945408945 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6538086" @default.
• W2945408945 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31129603" @default.
• W2945408945 hasPublicationYear "2019" @default.
• W2945408945 type Work @default.
• W2945408945 sameAs 2945408945 @default.
• W2945408945 citedByCount "14" @default.
• W2945408945 countsByYear W29454089452019 @default.
• W2945408945 countsByYear W29454089452020 @default.
• W2945408945 countsByYear W29454089452021 @default.
• W2945408945 countsByYear W29454089452022 @default.
• W2945408945 countsByYear W29454089452023 @default.
• W2945408945 crossrefType "journal-article" @default.
• W2945408945 hasAuthorship W2945408945A5011164326 @default.
• W2945408945 hasAuthorship W2945408945A5015611967 @default.
• W2945408945 hasAuthorship W2945408945A5039501435 @default.
• W2945408945 hasAuthorship W2945408945A5048905515 @default.
• W2945408945 hasAuthorship W2945408945A5052636813 @default.
• W2945408945 hasAuthorship W2945408945A5059382937 @default.
• W2945408945 hasAuthorship W2945408945A5074251150 @default.
• W2945408945 hasBestOaLocation W29454089451 @default.
• W2945408945 hasConcept C118552586 @default.
• W2945408945 hasConcept C126322002 @default.
• W2945408945 hasConcept C142724271 @default.
• W2945408945 hasConcept C168563851 @default.
• W2945408945 hasConcept C204787440 @default.
• W2945408945 hasConcept C27081682 @default.
• W2945408945 hasConcept C2776087441 @default.
• W2945408945 hasConcept C2776319443 @default.
• W2945408945 hasConcept C2776970978 @default.
• W2945408945 hasConcept C2777053506 @default.
• W2945408945 hasConcept C2777843972 @default.
• W2945408945 hasConcept C2779547902 @default.
• W2945408945 hasConcept C2780687700 @default.
• W2945408945 hasConcept C42219234 @default.
• W2945408945 hasConcept C71924100 @default.
• W2945408945 hasConceptScore W2945408945C118552586 @default.
• W2945408945 hasConceptScore W2945408945C126322002 @default.
• W2945408945 hasConceptScore W2945408945C142724271 @default.
• W2945408945 hasConceptScore W2945408945C168563851 @default.
• W2945408945 hasConceptScore W2945408945C204787440 @default.
• W2945408945 hasConceptScore W2945408945C27081682 @default.
• W2945408945 hasConceptScore W2945408945C2776087441 @default.
• W2945408945 hasConceptScore W2945408945C2776319443 @default.
• W2945408945 hasConceptScore W2945408945C2776970978 @default.
• W2945408945 hasConceptScore W2945408945C2777053506 @default.
• W2945408945 hasConceptScore W2945408945C2777843972 @default.
• W2945408945 hasConceptScore W2945408945C2779547902 @default.
• W2945408945 hasConceptScore W2945408945C2780687700 @default.

• next